Heritage Medical Research Institute Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2007
NCT00446472
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

aluminum hydroxide (Gaviscon) (1 trial)

becaplermin (regranex) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2